-
BMS Immunotherapy Combo Gets Two FDA Nods for GI Cancers in Span of a Week
13 Apr 2025 15:14 GMT
… drug combination for adults and children age 12 and older whose colorectal cancer … line of treatment — after anti-androgen drugs and … Pharmaceuticals developed to treat allergic reactions to insect bites, medications … trial. Among the concerns raised by the FDA …
-
First Patient Dosed With KSQ-004EX In Solid Tumor Clinical Trial
12 Apr 2025 16:22 GMT
… squamous cell carcinoma (HNSCC), colorectal cancer (CRC), pancreatic cancer and … trial being to evaluate the safety and tolerability of the drug … TIL therapy for the treatment of solid tumors,” said … their slumber. But that treatment also induces some unpleasant …
-
Integration of scRNA-Seq and Bulk RNA-Seq Identifies Circadian Rhythm Disruption-Related Genes Associated with Prognosis and Drug Resistance in Colorectal Cancer Patients
11 Apr 2025 12:56 GMT
… colorectal cancer in older patients: determinants of outcomes. J Pers Med … , pharmacology, and therapeutic interventions. J Pharmacokinet Pharmacodyn. … and drug response in colorectal cancer. EBioMedicine … with colorectal cancer risk and treatment outcomes. …
-
Bristol Myers Squibb's Opdivo plus Yervoy gets US FDA nod to treat adult and pediatric patients with mismatch repair deficient colorectal cancer
10 Apr 2025 05:32 GMT
… that the US Food and Drug Administration (FDA) approved Opdivo (nivolumab) plus … for additional treatment options. We are thrilled with this US FDA approval … /dMMR metastatic colorectal cancer.”
In the CheckMate-8HW trial, Opdivo plus Yervoy …
-
At-Home Testing: How Can Pharmacy Play a Role?
11 Apr 2025 19:54 GMT
… health tests and Reese Pharmaceuticals' colorectal cancer screening test, highlighting … key opportunities for pharmacies, including expanding diagnostic services … They stressed that pharmacies are evolving from medication dispensaries to comprehensive …
-
FDA Approves Nivolumab with Ipilimumab for Unresectable or Metastatic Colorectal Cancer
10 Apr 2025 01:44 GMT
… deficient (dMMR) colorectal cancer (CRC). The FDA also converted the … one of the following treatments:
nivolumab 240 mg … Programs for Serious Conditions-Drugs and Biologics.
Subscribe … special offers
from American Pharmaceutical Review – all delivered …
-
From Diagnosis to Therapy: Pharmacists Can Help Close the Gap in Colorectal Cancer Treatment
09 Apr 2025 23:37 GMT
… and clinics when integrating pharmacists into metastatic CRC (mCRC … Pharmacy Times: Why is biomarker testing so critical in the treatment … of metastatic colorectal cancer, especially given … for these patients.
Pharmacy Times: How do …
-
FDA approves nivolumab with ipilimumab for MSI-H, dMMR colorectal cancer
09 Apr 2025 21:23 GMT
… that has progressed following treatment with fluoropyrimidine, oxaliplatin, … because of the trial’s predefined statistical … MSI-H or dMMR colorectal cancer. FDA. Press release. April … .fda.gov/drugs/resources-information-approved-drugs/fda …
-
FDA Approves Bevacizumab Biosimilar for Various Cancer Types
11 Apr 2025 18:41 GMT
… is indicated to treat colorectal cancer, non-small cell lung … treatment of colon cancer.1
"The US FDA … similarity to the reference drug. The package confirmed … Alymsys (bevacizumab-maly; Amneal Pharmaceuticals), Vegzelma (bevacizumab-adcd; Celltrion …
-
FDA Approves Nivolumab With Ipilimumab for First-Line Treatment of Adult Patients With HCC
11 Apr 2025 18:40 GMT
… or mismatch repair deficient colorectal cancer in adult and pediatric … sorafenib (Nexavar; Bayer HealthCare Pharmaceuticals Inc.) or lenvatinib (Lenvima; … 0001).1,5
About the Trial
Trial Name: A Study of … the FDA news release.1 Grade 3 and 4 treatment- …
About
© 1995-2025